A Leader in Clinical Research
Clinical Trials at UMDNJ

FEATURES

Aging
Confronting Alzheimer’s • Decoding Dementias • Parkinson’s, Anxiety and Depression • Exercising the Aging Brain • Moving Forward • Nursing Research Fosters Independence

Pediatrics
Where Kids Volunteer • The Doctor’s Orders: A Cure • More Options for Kids’ Psychiatric Problems • Autism Therapies on Trial

Inflammation
Diagnosis: Scleroderma • Beyond the Standard of Care • The Old Exercise Remedy • For Her Patients’ Sake

Cancer
Staying Alive • New Trials to Beat Cancer • Recruiting Minorities for Cancer Trials • Adding Years With Experimental Therapies • Promising Medicines to Try • Trials for Gastrointestinal Malignancies

Dentistry
Smiling Once Again • The Puzzle of Burning Mouth Syndrome • Down in the Mouth

Women’s Health
Targeting Women’s Cancers • Putting Women First • Help for Headaches • Bringing Basic Science to the Clinic • Sleep and Fibromyalgia Symptoms

Cardiology
Protecting the Heart [and the Brain] • 911: Endangered Heart

Environment
On the Road Again • What’s in the Paint? • Treating Tobacco Dependency and Mental Illness • Kids and Their Environments: a Landmark Study • The Cancer/Clock Connection

Infection
Healthy Volunteers: The Inside Scoop • HIV Has A Female Face • Liver Disease: de la Torre's Dilemma • TB Trials: Secrets to Success

Community
Man with a Mission • Numbers Count  • Battling TB Here and Abroad • Breaking Down Barriers to Cancer Care • Her Happy Ending for HIV Pregnancy • Triggering Change in Transfusion Medicine

Endpage
Five Questions with Paula Bistak

Your comments and letters are welcome. Please send them to:

umdnjeditor@umdnj.edu

UMDNJ-University Marketing Communications
Unversity Heights
65 Bergen Street
P.O. Box 1709, Suite 1328
Newark, NJ 07101-1709

 

Women's Health
Help for Headaches
words by mary ann littell / photograph by pete byron


loretta Mueller, do, ASSOCIATE PROFESSOR AND DIRECTOR, UNIVERSITY HEADACHE CENTER , UMDNJ-SCHOOL OF OSTEOPATHIC MEDICINE

L
print this
Share this:

oretta Mueller, DO, has been principal or co-investigator for more than 50 clinical trials since beginning her career in the early 1990s. She has studied most of the migraine medications that have been approved during this exciting time for headache research.

Mueller has just finished enrolling patients for a totally new drug class for alleviation of migraine headaches, called a calcitonin-gene related peptide antagonist, which is not believed to cause blood vessel constriction (an issue with using migraine-specific medicines in patients with risk factors or known heart disease). She is also author and principal investigator of a funded, investigator-initiated study examining headache recurrences that occur more than a day after initial relief with medication, and looking at quality of life and satisfaction scales in reference to recurrence.